Sharda Cropchem Limited has informed the Exchange regarding Board meeting held on July 25, 2025.
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharda Cropchem's Board approved the unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025). Consolidated revenue from operations rose to ₹98,481 lakhs, up about 25% from ₹78,511 lakhs in the same quarter last year. Net profit surged to ₹14,280 lakhs (EPS ₹15.83), compared to ₹2,725 lakhs (EPS ₹3.02) in Q1 FY25. Profit before tax jumped to ₹16,914 lakhs from ₹3,079 lakhs, aided partly by a large foreign exchange gain of ₹7,309 lakhs. The agrochemicals segment remains the main revenue driver, with the company noting that Q1 results are not representative of full-year performance due to seasonality. Auditor B S R & Co. LLP issued an unmodified (clean) limited review report on both standalone and consolidated results.
A sharp jump in both revenue (~25% YoY) and net profit (over 5x YoY) is a positive earnings surprise, though part of the profit lift comes from favourable forex movement. With a clean audit report and no negative flags, the results are likely to support a constructive short-term stock reaction, but investors should keep seasonality in mind when extrapolating Q1 numbers to the full year.